The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified because of its key role in the regulation of glycogen synthesis. However, it is now well-established that GSK-3 performs critical functions in many cellular processes, such as apoptosis, tumor growth, cell invasi...

Full description

Bibliographic Details
Main Authors: Giuseppa Augello, Maria R. Emma, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, James A. McCubrey, Melchiorre Cervello
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/6/1427